|Author(s)/Faculty: Rishi P. Singh, MD; Netan Choudhry, MD, FRCSC, DABO; Sophie J. Bakri, MD; Sumit Sharma, MD; Valerie Zimmerman, PhD|
The continued refinement of treatment protocols for the management of retinal diseases provides the potential to enhance visual acuity outcomes, reduce treatment burden, and improve patient quality-of life measures when incorporated into practice. Emerging therapies with novel mechanisms of action or methods for delivery are also showing promise for the advancement of patient outcomes. Keeping abreast of these advances along with optimally incorporating them into everyday practice can be a challenge. In this publication series, expert retina specialists will discuss recent innovations and new technologies in imaging for diagnosis and disease monitoring; evaluate new technologies, devices, and techniques to enhance outcomes from vitreoretinal surgery; and assess the latest findings on safety and efficacy of current, new, and emerging therapies for optimal medical treatment of retinal diseases.